Comparison of Intra-operative Radiotherapy With Post-operative Radiotherapy for Women With Ductal Carcinoma in Situ
NCT ID: NCT02389699
Last Updated: 2015-03-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
74 participants
INTERVENTIONAL
2014-06-30
2024-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intra-operative Radiotherapy For Women With Ductal Carcinoma in Situ Breast Cancer
NCT02389673
Comparison Between IORT and Postoperative Radiotherapy in Breast Conserving Surgery
NCT04789889
The Postoperative Radiotherapy in N1 Breast Cancer Patients
NCT05440149
Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in Situ or Invasive Breast Cancer
NCT00054301
A Phase Ⅲ Randomized Clinical Trial of Postmastectomy Hypofractionation Radiotherapy in High-risk Breast Cancer
NCT00793962
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intraoperative Radiotherapy
Boost with 20 Gy during BCS, EBRT with 46-50 Gy
Intraoperative Radiotherapy
Boost with 20 Gy during BCS, EBRT with 46-50 Gy
whole breast radiation
WRT:whole breast radiation after BCS with 46-50 Gy
Whole breast radiation
whole breast radiation after BCS with 46-50 Gy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intraoperative Radiotherapy
Boost with 20 Gy during BCS, EBRT with 46-50 Gy
Whole breast radiation
whole breast radiation after BCS with 46-50 Gy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Intermediate or high grade ductal carcinoma in situ
* Informed consent
Exclusion Criteria
* Tumor size \> 3,5 cm
* Low grade ductal carcinoma in situ
* Invasive carcinoma
* No indication for a boost
18 Years
70 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Liao Ning
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Liao Ning
Guangdong Academy of Medical Sciences
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Liao Ning, MD,PhD
Role: STUDY_DIRECTOR
Guangdong Academy of Medical Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Guangdong Academy of Medical Sciences
Guangzhou, Guangdong, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GGHBCRG-IORT-WRT-DCIS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.